Corporate Responsibility

Dr. Ron Jurgensen, Newport Beach Dentist Celebrates 30 Years of Humanitarian Service in Third-World Countries – Offering Hope Where there is None

October 13, 2017

Dr. Ron Jurgensen, Newport Beach Dentist Celebrates 30 Years of Humanitarian Service in Third-World Countries – Offering Hope Where there is None Every year for the past 30 years, Dr. Jurgensen has spent his vacations relieving the unimaginable suffering of impoverished people who have no access to dental care or hygiene. Newport Beach, Calif., October […]

CPhI Worldwide to support International Medical Corps UK with global charity partnership

October 9, 2017

Amsterdam, 4th October 2017: CPhI Worldwide, organised by UBM, announces a new dedicated charity partnership with International Medical Corps UK. Thecollaboration will see UBM extensively promote International Medical Corps across the global pharma community, with a range of fundraising and customised sponsorship packages. International Medical Corps UK was selected in light of its vital work in […]

HBAdvantage: Leadership in Action – Spring 2017

May 12, 2017

This year marks a special milestone for the Healthcare Businesswomen’s Association. Forty years ago, five courageous women  came together in New York with a shared passion to make the advertising and medical journal world of healthcare a place where women could not just survive but thrive. (Please turn to page 10 for more about the remarkable evolution/revolution of the HBA.) And since this […]

The Canadian Institute’s 3rd Annual Pharma Symposium

March 23, 2017

The Canadian Institute’s 3rd Annual Pharma Symposium The Road Ahead: From Clinical Trial to Market Access May 30-31, 2017 | One King West | Toronto Join us at The Canadian Institute’s 3rd Annual Pharma Symposium on May 30-31, 2017, where you’ll learn about the key issues facing the industry in today’s environment. Hear from a […]

Leveraging FDA’s Expedited Programs: Now and in the Future

March 14, 2017

FDA is committed to advancing the development of therapies that treat serious conditions and rare diseases. As part of this commitment, FDA offers expedited programs for biopharmaceutical companies to reduce development and review timelines for new drugs and biologics that address unmet medical needs. In this webinar, Cardinal Health regulatory experts will examine FDA’s four […]

Designing Effective Patient Assistance Programs (PAPs)

February 6, 2017

While economic reforms drive sweeping changes in healthcare, the reimbursement and access landscape for specialty drugs continues to grow more challenging. For patients facing serious illnesses and their healthcare providers, navigating the prior-authorization requirements and other barriers to care can be overwhelming. Many specialty drug manufacturers are taking steps to help patients overcome these access […]

An Advocacy Rx for Progress in Mental Health

January 31, 2017

Through sustained partnerships between advocacy and industry, the US and Europe can overcome barriers to care. As a source of human suffering, a barrier to workplace productivity, a burden on families and a driver of medical costs, mental illness amounts to an unparalleled public health crisis. Fortunately, there’s an abundance of smart thinking on how to improve the […]

Mental Health: Payer and Advocacy Perspectives in a Time of Policy Uncertainty

January 26, 2017

Heather Gartman discusses patient advocacy in the mental health space, including problem with underfunded research, the numerous stakeholders involved, and ways pharma and these stakeholders can come together to better support this extremely important area of the healthcare ecosystem. Also download our related white paper below, entitled, An Advocacy Rx for Progress in Mental Health.

Inspiring Hope Ideathon

January 1, 2017

The Inspiring Hope Ideathon is a unique crowdsourcing event, which was co-hosted by INC Research, a global CRO committed to bringing innovation and value to customers, clinical research sites, and patients, and the nonprofit Center for Information and Study on Clinical Research Participation (CISCRP). The event brought together nearly 70 novel ideas to increase the […]

HBAdvantage: Achieving Gender Parity – Fall 2016

November 18, 2016

The Healthcare Businesswomen’s Association’s refreshed mission and subsequent strategic plan has been in place throughout 2016. As we move toward our goal of gender parity through gender partnership, we can look to current research to see where we are. We are working toward gender parity in leadership positions. We are partnering with organizations and companies that have parallel missions and vision. We are […]

Preparing for the Silver Tsunami: The Intersection of Healthcare and Technology

June 1, 2016

With more than 10,000 people a day turning 65 in the United States — equating to more than 2 billion seniors by 2050 — the healthcare industry needs to prepare to meet the demands of this older population. Patient care and technology are converging, and together they have the ability to improve the lives of […]

HBAdvantage: Transforming the Future – Spring 2016

April 28, 2016

Each May, for more than a quarter of a century, the HBA has filled the largest ballroom in New York City to celebrate extraordinary women leaders in the healthcare industry. Over the years, we’ve heard inspirational stories of leadership, transformation and innovation. This year, we thank those attending the Woman of the Year (WOTY) event in […]

HBAdvantage: Transforming the Future – March 2016

March 29, 2016

The HBA is embarking on a bold approach to transform the future of the healthcare industry: achieve gender parity. This issue of HBAdvantage focuses on numerous related issues. This pivot in direction first began in 2015 as the HBA’s board of directions re-evaluated the organization’s strategic plan based on feedback from key members of its advisory […]

How Pharma can turn the trend of the decade into a leadership advantage

March 1, 2016

The World Economic Forum has named collaboration as the key to global growth: public-private partnerships between companies large and small, NGOs, government agencies and academia are the single largest corporate trend of the decade. And why? The world’s problems are increasingly those that can only be solved by the best and brightest from a wide […]

Great Information on Rare Diseases and Orphan Drugs

February 8, 2016

If you work in the rare disease space, you will be very interested in this blog post. Publicis Touchpount Solutions recently published an outstanding white paper on rare diseases and orphan drugs. It’s packed with valuable statistics, research findings, images, and charts. Compared to most white papers, it’s a fairly deep dive, with 25 pages […]

Patients Defend Afrezza

January 13, 2016

Written by: Robin Robinson, Senior Editor, PharmaVOICE Magazine On Friday, Jan. 8, 2016, PharmaVOICE featured a news story quoting a third party in its This Week’s News In Review regarding Sanofi’s decision to dissolve the marketing partnership for Afrezza with MannKind. Readers in support of MannKind reached out to us to show their support for […]